Takeda unit urges Fed Circ to revive antibody patent

Baxalta, a subsidiary of Japan-headquartered pharmaceutical company Takeda, has asked the US Court of Appeals for the Federal Circuit to overturn a decision that invalidated its antibody patent.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

10 August 2026 Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law.

Regulation & Industry

Kirkland clears conflicts hurdle in trade secrets spat

7 August 2026 A federal judge has refused to disqualify Kirkland & Ellis from representing a healthcare tech company after a conflict check came under scrutiny.

Careers

Former senior attorney-advisor to ITC commissioners joins Mintz

7 August 2026 After more than 14 years at the US International Trade Commission, the new hire says he was drawn to Mintz for its “continued growth in the life sciences sector”.

More features

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

Kirkland clears conflicts hurdle in trade secrets spat

Former senior attorney-advisor to ITC commissioners joins Mintz

The UPC plugs another gap in its procedural rulebook

Novo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers

Brown Rudnick lands largest lateral IP team hire in firm history

Fran Salisbury: ‘There’s nothing quite like finding the missing piece’

K&L Gates expands European practice with Munich team hire

Takeda unit urges Fed Circ to revive antibody patent

More on this story

Editor's picks

Editor's picks

More features